Distribution of hotspots matching specific human Kegg-pathways. ... Fully expanded scatterplot of all 210 KEGG pathways with function potential hotspots of.
S3: Villi whole mounts from WT and CLIP1/CLIP2 double KO small intestinal stained for the apical marker gp-135 (green), MTs (red) and DAPI (blue) indicating ...
Supplementary Table 1. Band Gene name Unique peptides [#] Sequence coverage [%] Gene ID Molecular weight [kDa]. 1. THRAP3. 41. 34. 9967. 109 kDa.
analyzed by 12% SDS-PAGE with Coomassie Brilliant Blue staining. (A) Purified human and chicken. RAD51. (B) Purified chicken FANCI, FANCD2, His6-FANCI ...
di Verona. .... RNF213, a new nuclear marker for acanthomorph phylogeny. ... Nelson, J. S. Fishes of the World (Wiley & Sons, Hoboken, New Jersey, 2006).
All 18 subjects on basal insulin, 13 on basal-bolus;. 9 subjects were also on metformin (5 on basal-bolus,. 3 basal insulin only, 1 basal insulin only + repaglinide;.
A full-length cDNA of OsSRO1c isolated from indica rice Guang-lu-ai 4 was obtained from the Rice Indica cDNA Database (http://www.ncgr.ac.cn/ricd/) (Liu et al., ...
Figure S2. The distribution of cofold structures in the sequenced random library and computer ... The RNA sequences were cofolded with the SR1 adapter.
Supplementary data 1. Morphology of cGMP-compliant hPSCs maintained as colonies on Vitronectin-XF cell culture matrix. Brightfield microscopy images.
Komiya R, Ikegami A, Tamaki S, Yokoi S, Shimamoto K. 2008. Hd3a and RFT1 .... Voogd C, Brian LA, Wang T, Allan AC, Varkonyi-Gasic E. 2017. Three FT and ...
Jan 11, 2017 - For the 10 human datasets, 9 datasets did not have the KO gene in KEGG. The last dataset, GSE2781, involves both human and mouse cells ...
eIF3a/TIF32 and Progressively Folded cis-Acting mRNA Elements Preceding. Short uORFs. PLoS Genet, 7, e1002137. 5. Mueller, P.P. and Hinnebusch, A.G. ...
Corresponding author: Dieter Henrik Heiland. Department of Neurosurgery. Medical Center - University of Freiburg. Faculty of Medicine, University of Freiburg.
TAG 56:9. TAG 58:5. TAG 58:6. TAG 58:7. TAG 58:8. TAG 58:9. 0. 10. 20. 30. 40. 50 ... CE 16:0. CE 16:1. CE 17:1. CE 18:1. CE 18:2. CE 18:3. CE 19:2. CE 20:2.
Laboratory of Chemo/biosensing and Chemometrics, College of Physics and ... 3Department of Chemistry and Biochemistry and California NanoSystems ...
[2] Yunxia Wang, Lianxin Yang, Kazuhiko Kobayashi, Jianguo Zhu, Charles P ... [6] Yuxuan Wang, Lulu Shen, Shiliang Wu, Loretta Mickley, Jingwei He, and ...
(Illumina) low-coverage samples from the 1000 Genomes Project. ... approach using high-coverage samples from Complete Genomics public repository.
1:10,000. Jackson. ImmunoResearch. 715-035-150 1:10,000. SUZ12. Santa Cruz. Biotechnology, Inc. sc-67105. 1:500. Santa Cruz. Biotechnology, Inc. sc-2030.
Device and Sensor Specifications. Table S1 summarizes the specifications of the new VOC device with a MIP-modified TF sensor. (MIP-TF sensor) for detection ...
failures may take the form of corrupted storage media, or ... Redundant array of independent disks (RAID) âis a method by .... Failure Trends in a Large Disk Drive.
the single nucleotide positions within each peak where the ChIP-seq signal is ... identified by the original ChIP-seq peak calling in any of the included samples.
PhG, Parahippocampal Gyrus. Entorhinal Area, Parahippocampal Gyrus. 12. Psts, Posterior Superior Temporal. Sulcus. Banks of the Superior Temporal Sulcus.
type and IC3 mutant CRH-R1α receptors, was assessed in cell membranes-rich fractions by. Scatchard analysis using. 125I-Tyr0-sauvagine (50pM-5nM) and ...
SUPPLEMENTARY DATA SD-Figure 1 Comparison by western blot analysis of wild type and mutant CRH-R1α receptor expression in HEK293 cell membranes. Cell membrane proteins from HEK293 cells transiently expressing wild type or mutant CRH-R1α receptors were prepared using ProteoExtract® Native Membrane Protein Extraction Kit as described in Experimental Procedures and were fractionated on SDS-PAGE, transferred to and subjected to immunoblotting with a specific CRH-R1/2 antibody and IRDye™ 800 secondary antibody, using the Odyssey detection system, or immunoblotted with a anti-cadherin antibody and visualized with ECL. Representative Western blots are shown: identical results were obtained from 3 independent transfection experiments. Similar results were obtained when mutants R1αI293A, R1αK297A, R1αR299A and R1αR310A were transiently expressed in HEK293 cells (data not shown)
SD-Figure 2 Effect of Gi-protein activators/inhibitors on Ucn1-induced cAMP release from HEK293 cells expressing wild type CRH-R1α receptors. HEK293 cells, transiently expressing wild type CRH-R1α as described in Experimental Procedures, were pre-treated with or without (a) pertussis-toxin (PTX) for 12 h, (final concentration, 100 ng/ml) or mastoparan the wasp venom-derived peptide (20 µM for 1h), to inactivate or activate Gi/o-proteins respectively, before stimulation with different concentrations of Ucn1 (0.1-1000nM) for 15min cells. In some experiments, cells overexpressing a dominant-negative Gαi(Q205L/D273N) were pre-treated with 20 µM mastoparan (b) or the suramin analogue NF023 (100nM for 2h) (c) prior to stimulation with Ucn1 (100nM) (b). Cyclic AMP was measured by ELISA and responses (measured as Ucn1-induced cAMP fold increase above basal) shown represent the mean ±SEM of 3 estimations from three independent experiments. *, P